JDR JDR Most Cited Articles
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, Z.
Right arrow Articles by Yu, G.Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, Z.
Right arrow Articles by Yu, G.Y.

Functional {alpha}1-Adrenoceptor Subtypes in Human Submandibular Glands

Z. Huang1, L.L. Wu2,*, Y.Y. Zhang3, Y. Gao4, and G.Y. Yu1,*

1 Department of Oral and Maxillofacial Surgery and
4 Department of Oral Pathology, Peking University School and Hospital of Stomatology, Zhong Guan Cun South St. 22, 100081 Beijing, PRC;
2 Department of Pathophysiology, Peking University Health Science Center; and
3 Institute of Vascular Medicine, Peking University Third Hospital, Beijing, PRC


Figure 1
Figure 1
View larger version (169K):

[in a new window]
 
Figure 1. The gene imaging and protein expression of {alpha}1-adrenoceptor subtypes in human submandibular glands. RT-PCR products from human submandibular glands were eletrophoresed on 2% agarose gels and visualized with ethidium bromide. M, Marker (100-bp DNA ladder; the lightest band is 500 bp). (A,B,C) {alpha}1A-, {alpha}1B-, and {alpha}1D-adrenoceptor gene expression, respectively. Lane 1 in A, B, and C indicates RT-PCR product amplified from human {alpha}1-adrenoceptor subtype full-length cDNA, as a positive control. Lane 2 in A, B, and C indicates RT-PCR product without using reverse-transcriptase, as a negative control. Lane 3 in A, B, and C indicates RT-PCR product amplified from human submandibular gland. (D,E,F) RT-PCR products of {alpha}1A-, {alpha}1B-adrenoceptor and ß-actin amplified from individuals. (G) Comparison of the relative amounts of transcripts for {alpha}1A-adrenoceptor subtype mRNA with {alpha}1B-adrenoceptor subtype mRNA. Data were expressed as mean ± SEM (n = 10, P < 0.05). (H,I) {alpha}1A- and {alpha}1B-adrenoceptor gene expression by in situ hybridization (paraffin section), respectively. Intracytoplasmic hybridization signal was observed in acinar and ductal cells. (J,K) {alpha}1A- and {alpha}1B-adrenoceptor protein expression by immunohistochemistry (frozen section), respectively. Intracytoplasmic and membrane staining was seen in acinar and ductal cells. (Arrow a indicates acinar cells, arrow d indicates ductal cells.) (L,M) {alpha}1A- and {alpha}1B-adrenoceptor protein expression by Western blotting. Intensively immunoreactive bands of 55 kDa and 60 kDa, corresponding to the {alpha}1A- and {alpha}1B-adrenoceptors, were detected. ’Cont’ indicates the positive control, with HEK293 cells transfected with the cDNAs encoding {alpha}1-adrenoceptor subtypes. Lanes 1, 2, and 3 in L and M, respectively, indicate the expression of {alpha}1A- and {alpha}1B-adrenoceptors in human submandibular glands from three persons.

 

Figure 2
View larger version (18K):

[in a new window]
 
Figure 2. Effects of {alpha}1-adrenoceptor subtype selective agonists and antagonist on [Ca2+]i in human submandibular gland cells. (A,C,E) Fluorescence image of fluo-3AM-loaded cells before treatment with phenylephrine, A61603, or 5-methylurapidil. No change in [Ca2+]i fluorescence intensity (FI) was observed after pre-treatment with 5-methylurapidil (E). There were no marked differences in FI among A, C, and E. The maximum of FI was observed at about 1500 sec after agonist treatment. (B,D) A significant increase in [Ca2+]i FI at the individual cell level after treatment with phenylephrine (1 µM) or A61603 (100 µM), respectively. (F) A mild increase in [Ca2+]i FI at the individual cell level with 1 µM of phenylephrine after pre-treatment with 5-methylurapidil (0.1 µM). (G) The dynamics of FI at the individual cell level treated with phenylephrine, A61603, or 5-methylurapidil plus phenylephrine in the human submandibular gland cells. (H) Fluorescence image of fluo-3AM-loaded cells with KCl stimulation (50 mM).

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
IADR Journals Advances in Dental Research ®
Journal of Dental Research ® Critical Reviews (1990-2004)
Copyright © 2006 Institutional Access Guidelines